Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting individuals who carry a premutation expansion of the FMR1 gene[@jacquemont2004]. FXTAS is characterized by progressive cerebellar ataxia and intention tremor, with additional features including peripheral neuropathy, autonomic dysfunction, and cognitive decline[@hagerman2020].
Epidemiology
Prevalence: FXTAS affects approximately 1 in 450-500 males and 1 in 150-300 females who carry the FMR1 premutation[@tassone2012]
Age of Onset: Typically begins in the sixth decade of life (50s-60s)
Penetrance: Full penetrance by the eighth decade in males; females typically have milder symptoms due to X-inactivation
Sex Distribution: More common and severe in males, reflecting the single X chromosome in males
Genetics
FMR1 Premutation
FXTAS occurs in individuals carrying an intermediate allele (55-200 CGG repeats) known as a premutation[@jacquemont2004]:
Normal: < 45 CGG repeats
Premutation: 55-200 CGG repeats
Full Mutation: > 200 CGG repeats (causes Fragile X syndrome)
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting individuals who carry a premutation expansion of the FMR1 gene[@jacquemont2004]. FXTAS is characterized by progressive cerebellar ataxia and intention tremor, with additional features including peripheral neuropathy, autonomic dysfunction, and cognitive decline[@hagerman2020].
Epidemiology
Prevalence: FXTAS affects approximately 1 in 450-500 males and 1 in 150-300 females who carry the FMR1 premutation[@tassone2012]
Age of Onset: Typically begins in the sixth decade of life (50s-60s)
Penetrance: Full penetrance by the eighth decade in males; females typically have milder symptoms due to X-inactivation
Sex Distribution: More common and severe in males, reflecting the single X chromosome in males
Genetics
FMR1 Premutation
FXTAS occurs in individuals carrying an intermediate allele (55-200 CGG repeats) known as a premutation[@jacquemont2004]:
Normal: < 45 CGG repeats
Premutation: 55-200 CGG repeats
Full Mutation: > 200 CGG repeats (causes Fragile X syndrome)
The premutation allele leads to:
Elevated FMR1 mRNA: The expanded CGG repeat causes aberrant methylation and increased transcription, resulting in 2-8 times normal FMR1 mRNA levels[@primerano2002]
RNA Toxicity: The expanded mRNA forms toxic foci that sequester proteins essential for neuronal function
Repeat-Associated Non-ATG Translation (RAN Translation): The CGG repeat can be translated in all three reading frames, producing toxic polyglycine, polyalanine, and polycysteine proteins[@todd2013]
Key Genes
FMR1 (Fragile X Mental Retardation 1): The causative gene; located on chromosome Xq27.3
FMRP (Fragile X Mental Retardation Protein): The protein product, which is deficient in full mutation carriers but typically normal in premutation carriers
Pathophysiology
Molecular Mechanisms
RNA Toxicity: Elevated FMR1 mRNA with expanded CGG repeats forms secondary structures that sequester essential RNA-binding proteins[@hagerman2020]
Pur-alpha, hnRNP A2/B1, and other proteins involved in mRNA transport and translation are sequestered into RNA foci
This leads to dysregulation of dendritic mRNA translation critical for synaptic plasticity
RAN Translation: Non-ATF translation of the CGG repeat produces toxic polyglycine-containing proteins (FMRpolyG)[@todd2013]
FMRpolyG accumulates in neuronal nuclei
Causes ubiquitin-positive inclusions in [neurons](/entities/neurons) and [astrocytes](/entities/astrocytes)
Leads to mitochondrial dysfunction and oxidative stress
Mitochondrial Dysfunction:
FMRpolyG localizes to mitochondria
Impairs mitochondrial energy production
Increases [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) production
Contributes to neuronal vulnerability
Neuroinflammation:
Activated [microglia](/cell-types/microglia-neuroinflammation) and astrocytes in affected brain regions
Elevated cytokines including IL-1β, TNF-α, and IL-6
Contributes to progressive neuronal loss
Neuropathology
Brain Atrophy: Cerebellar atrophy (especially of the cerebellar vermis) and cerebral white matter changes
Intranuclear Inclusions: Ubiquitin-positive, FMRpolyG-containing inclusions in neurons and astrocytes throughout the brain[@hagerman2020]
Loss of Purkinje Cells: Degeneration of cerebellar Purkinje cells contributes to ataxia
White Matter Hyperintensities: MRI shows T2/FLAIR hyperintensities in the middle cerebellar peduncles (MCP signs) and periventricular white matter
Affected Brain Regions
Cerebellum: Particularly the vermis and hemispheres — accounts for ataxia
Basal Ganglia: Contributes to tremor
Brainstem: Involvement of red nucleus and inferior olivary nucleus
Cerebral White Matter: Diffuse white matter disease